Comparing the effect of Verapamil and triamcinolon in Hypertrophic scar treatment
Phase 2
- Conditions
- Hypertrophic scar.Keloid scar
- Registration Number
- IRCT2016010425539N5
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with hypertrophic scar and keloid which had not any other treatment and after accept of survey condition to come montly for enjection.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypertrophic scar. Timepoint: The month 0, 1, 2 during treatment and 1 month after treatment. Method of measurement: The highest elevation of hypertrophic scar with calliper and ruler.
- Secondary Outcome Measures
Name Time Method Patient satisfaction from treatment. Timepoint: After treatment. Method of measurement: The percentage and score of the patient to treatment.